TNFRSF13B gene mutation in familial acute myeloid leukemia: A new piece in the complex scenario of hereditary predisposition?
Cosimo CumboPaola OrsiniFrancesco TarantiniLuisa AnelliAntonella ZagariaVincenzo TragniNicoletta CoccaroGiuseppina TotaElisa ParcianteMaria Rosa ConservaImmacolata RedavidCrescenzio Francesco MinerviniAngela MinerviniImmacolata AttolicoMattia GentileCiro Leonardo PierriGiorgina SpecchiaPellegrino MustoFrancesco AlbanoPublished in: Hematological oncology (2023)
TNFRSF13B mutations are widely associated with common variable immunodeficiency. TNFRSF13B was recently counted among relevant genes associated with childhood-onset of hematological malignancies; nonetheless, its role in acute myeloid leukemia (AML) remains unexplored. We report the study of a family with two cases of AML, sharing a germline TNFRSF13B mutation favoring the formation of a more stable complex with its ligand TNFSF13: a positive regulator of AML-initiating cells. Our data turn the spotlight onto the TNFRSF13B role in AML onset, inserting a new fragment into the complex scenario of a hereditary predisposition to myeloid neoplasms.
Keyphrases
- acute myeloid leukemia
- allogeneic hematopoietic stem cell transplantation
- induced apoptosis
- healthcare
- social media
- electronic health record
- cell cycle arrest
- cell death
- acute lymphoblastic leukemia
- dendritic cells
- dna damage
- machine learning
- signaling pathway
- sensitive detection
- immune response
- young adults
- artificial intelligence